Skip to content

A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication

A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03105583
Acronym
PREVIM
Enrollment
381
Registered
2017-04-10
Start date
2016-12-31
Completion date
2018-01-31
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication and Supplement Use, Pregnant Women

Keywords

Medication beliefs, Information desire, Vitamin deficiencies

Brief summary

This cross-sectional study will try to give answers to the following project aims: * To provide an overview of the prevalence of health products' use among Belgian pregnant women (prescription and OTC medication, vitamin supplements, phyto-therapeutics, dermatologic products), including where pregnant women buy or get their health products (online web survey). * To document women's beliefs about medication during pregnancy and their information desire (online web survey). * To determine the current vitamin status among pregnant women and to reveal clinical targets for supplementing deficiencies in this population (blood sample analysis). The study will be performed at the obstetrics department of the University Hospitals of Leuven (campus Gasthuisberg). We aim to include 300 pregnant women (100 per trimester), of which 150 women will be asked to determine their vitamin status (50 per trimester).

Interventions

DRUGMedication use during pregnancy
DIETARY_SUPPLEMENTSupplement use during pregnancy
OTHERVitamin status of a pregnant woman

Haemoglobin, RBC count + hematocrits, thrombocytes count, folate (serum), vitamin B12, WBC count, ferritin, iron (serum), transferrin % and saturation, TSH, T4, free glucose, LDH, ALT, AST, GGT, bilirubin (total), CRP, albumin, total protein, ureum, uric acid, creating, calcium (total), 25-hydroxy vitamin D, Na, K, Mg

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women who visit the obstetrics department of the University Hospitals of Leuven * ≥18 years * Able to understand Dutch, French or English

Exclusion criteria

* \<18 years * Don't able to understand Dutch, French or English

Design outcomes

Primary

MeasureTime frameDescription
Medication and supplement use among Belgian pregnant womenCompletion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational agePercentage of women who have taken a health product during the last 7 days - Overview of the health products used by pregnant women

Secondary

MeasureTime frameDescription
Vitamin deficiencies among Belgian pregnant womenOne blood sample during pregnancy: between 8-12weeks or 24-32weeks gestational ageAnalysis of a blood sample
Medication beliefs among Belgian pregnant womenCompletion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational ageBeliefs about Medicines Questionnaire (BMQ) (R. Horne, H. Nordeng)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026